23 results
IDSA Recommendations for Preventing and Treating Penicillium marneffei Infections in HIV-AIDS
Preventing 1st Episode of Penicilliosis (Primary
IDSA Recommendations ... for Preventing ... to 5 mg/kg/day IV ... Penicilliosis #IDSA ... #management #opportunistic
IDSA Recommendations for Preventing and Treating Bacterial Enteric Infections in HIV-AIDS
Preventing Bacterial Enteric Illness:
 • Antimicrobial
IDSA Recommendations ... for Preventing ... PO (or 400 mg IV ... Enteric #Bacterial #IDSA ... #management #opportunistic
IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS
Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days)
Preferred
IDSA Recommendations ... detailed application instructions ... 400 mg) PO or IV ... #Prevention #Treatment ... #management #opportunistic
Acute ED Migraine Therapy and Preventative Therapy Algorithm:
Acute migraine
 • IV NS IL bolus then infusion
• Ketorolac IV ... 20 mg/min -> Neurology ... #Migraine #management ... algorithm #treatment #prevention ... #prophylaxis #neurology
IDSA Recommendations for Treating Visceral and Cutaneous Leishmaniasis in HIV-AIDS
Treating Visceral Leishmaniasis - Preferred Therapy:
 •
IDSA Recommendations ... amphotericin B 2–4 mg/kg IV ... Leishmaniasis #Prevention ... #Treatment #management ... #opportunistic
IDSA Recommendations for Treating Isospora belli Infection in HIV-AIDS
Treating Isospora belli Infection
General Management Considerations:
 • Fluid
IDSA Recommendations ... Infection General Management ... IsosporaBelli #IDSA ... #Prevention #Treatment ... #management #opportunistic
IDSA Recommendations for Treating Coccidiodomycosis in HIV-AIDS
Treating Mild Infections (Such As Focal Pneumonia or asymptomatic patients
IDSA Recommendations ... with positive serology ... 0.7–1.0 mg/kg IV ... #Prevention #Treatment ... #management #opportunistic
IDSA Recommendations for Preventing and Managing Cryptosporidiosis in HIV-AIDS
Preventing Chronic Cryptosporidiosis:
 • Because chronic cryptosporidiosis occurs
IDSA Recommendations ... for Preventing ... Aggressive oral and/or IV ... Cryptosporidiosis #IDSA ... #management #opportunistic
IDSA Recommendations for Preventing and Treating HHV-8 Diseases—Kaposi Sarcoma (KS), Primary Effusion Lymphoma (PEL), Multicentric Castleman’s
IDSA Recommendations ... for Preventing ... valganciclovir or IV ... KaposiSarcoma #Castlemans #IDSA ... #management #opportunistic
IDSA Recommendations for Preventing and Treating Cryptococcosis in HIV-AIDS
Treatment for cryptococcosis consists of 3 phases: induction,
IDSA Recommendations ... for Preventing ... #Cryptococcus #IDSA ... #Prevention #Treatment ... #management #opportunistic